The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
Jenelle K Bray, William A Goddard
Journal of molecular graphics & modelling August 1, 2008 DOI: 10.1016/j.jmgm.2008.02.006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Computational modeling study Peer reviewed |
|---|---|
| Duration | 5 ns molecular dynamics simulation |
| Topics | Serotonin |
| Keywords | Serotonin receptor 5-ht2c Receptor binding Receptor interaction Receptor function Structural differences 3d structure Detailed model Predictive modeling |
| Citations | 35 |
| Key points | The predicted 3D structure of the serotonin 5-HT(2C) receptor is sufficiently accurate for drug design, and a structural difference in TM5 explains distinct serotonin binding modes between 5-HT(2B) and 5-HT(2C). |
Abstract
We used the MembStruk computational procedure to predict the three-dimensional (3D) structure for the serotonin 5-HT(2C) G-protein-coupled receptor (GPCR). Using this structure, we used the MSCDock computational procedure to predict the 3D structures for bound ligand-protein complexes for agonists such as serotonin and antagonists such as ritanserin, metergoline, and methiothepin. In addition, we predicted the SAR data for a series of psilocybin analogs, both agonists and antagonists. We performed molecular dynamics (MD) on serotonin bound to 5-HT(2C) and we find the protein and binding site to be stable after 5ns. We find good agreement with the currently known experimental data and we predict a number of new mutations which could be used to validate further our predicted structures. This agreement between theory and experiment suggests that our 3D structure is sufficiently accurate for use in drug design. We also compare a preliminary prediction for 5-HT(2B) with our prediction for 5-HT(2C) and find a difference in TM5 that contributes to different serotonin binding modes in 5-HT(2B) and 5-HT(2C).
Citations in the library
Cited by 1
Cites 3
- Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. Journal of Biological Chemistry June 21, 1996
- SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist Bioorganic & Medicinal Chemistry Letters August 3, 2005
- Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. Molecular Pharmacology 2003